Photo: Food and Drug Administration, Public domain, via Wikimedia Commons
What It Is
Before any medication can legally be sold to patients in the United States, it must pass through one of the most rigorous compliance review processes in the world. The FDA's drug approval process requires pharmaceutical companies to conduct years of laboratory testing, followed by three phases of clinical trials involving thousands of human participants, before a compliance review team examines all evidence and decides whether the drug is safe and effective enough for approval. The entire process typically takes more than a decade and costs hundreds of millions of dollars, and at every stage, compliance specialists are the people responsible for verifying that the data meets the required standards and that nothing has been misrepresented. Drugs that fail any stage of the process cannot proceed, regardless of how promising they appear or how much the company has already invested in them.
Why It Matters
The FDA approval process exists because the alternative has repeatedly proven catastrophic. Before modern drug regulation, Americans had access to medications that contained cocaine, heroin, and toxic heavy metals, marketed without any evidence of safety or effectiveness. The thalidomide crisis in Europe, which the FDA helped the United States avoid thanks to Frances Kelsey, demonstrated what happens when compliance standards are insufficient. Today, the process is far from perfect, and debates about how to balance rigor with speed are ongoing, but the underlying principle that no drug reaches patients without independent verification of its safety and effectiveness is one that compliance specialists maintain on behalf of every person who takes a prescription medication. Behind every approved drug is a team of compliance professionals who checked the work.
